4//SEC Filing
Jayne David R.W. 4
Accession 0001628280-21-012385
CIK 0001600620other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 9:19 PM ET
Size
5.2 KB
Accession
0001628280-21-012385
Insider Transaction Report
Form 4
Jayne David R.W.
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-14+31,347→ 31,347 totalExercise: $12.86Exp: 2031-06-14→ Common Shares (31,347 underlying)
Footnotes (1)
- [F1]The option vests in twelve equal monthly installments commencing on July 14, 2021.
Documents
Issuer
Aurinia Pharmaceuticals Inc.
CIK 0001600620
Entity typeother
Related Parties
1- filerCIK 0001838242
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 9:19 PM ET
- Size
- 5.2 KB